Dan-Arin Silasi

1.1k total citations
7 papers, 190 citations indexed

About

Dan-Arin Silasi is a scholar working on Pharmacology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Dan-Arin Silasi has authored 7 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pharmacology, 2 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Dan-Arin Silasi's work include Drug-Induced Adverse Reactions (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). Dan-Arin Silasi is often cited by papers focused on Drug-Induced Adverse Reactions (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). Dan-Arin Silasi collaborates with scholars based in United States and Italy. Dan-Arin Silasi's co-authors include Masoud Azodi, Alessandro D. Santin, Peter E. Schwartz, Elena Ratner, Natália Buza, Stefania Bellone, Thomas Rutherford, Gary Altwerger, Emiliano Cocco and Gregory M. Gressel and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, Gynecologic Oncology and BMC Cancer.

In The Last Decade

Dan-Arin Silasi

7 papers receiving 189 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dan-Arin Silasi United States	7	82	45	39	38	33	7	190
Nicoletta Provinciali Italy	9	175 2.1×	83 1.8×	6 0.2×	54 1.4×	23 0.7×	22	308
Jian Gu China	10	71 0.9×	167 3.7×	8 0.2×	33 0.9×	13 0.4×	20	310
Taner Korkmaz Türkiye	12	189 2.3×	95 2.1×	5 0.1×	26 0.7×	10 0.3×	31	309
Slavomir Krajnak Germany	12	194 2.4×	69 1.5×	4 0.1×	37 1.0×	40 1.2×	35	313
Xingsheng Qiu China	10	92 1.1×	306 6.8×	11 0.3×	9 0.2×	20 0.6×	21	456
Areeg Faggad Sudan	12	96 1.2×	268 6.0×	5 0.1×	44 1.2×	8 0.2×	18	406
Kaijian Lei China	9	90 1.1×	108 2.4×	3 0.1×	16 0.4×	15 0.5×	38	294
Xuan Pei China	8	142 1.7×	120 2.7×	5 0.1×	23 0.6×	5 0.2×	17	311
Saranya Ravi United States	7	70 0.9×	91 2.0×	6 0.2×	21 0.6×	5 0.2×	12	292
Xiaoke Wu China	10	42 0.5×	291 6.5×	4 0.1×	17 0.4×	24 0.7×	25	393

Countries citing papers authored by Dan-Arin Silasi

Since Specialization

Citations

This map shows the geographic impact of Dan-Arin Silasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan-Arin Silasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan-Arin Silasi more than expected).

Fields of papers citing papers by Dan-Arin Silasi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan-Arin Silasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan-Arin Silasi. The network helps show where Dan-Arin Silasi may publish in the future.

Co-authorship network of co-authors of Dan-Arin Silasi

This figure shows the co-authorship network connecting the top 25 collaborators of Dan-Arin Silasi. A scholar is included among the top collaborators of Dan-Arin Silasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan-Arin Silasi. Dan-Arin Silasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Altwerger, Gary, Esther Borges Florsheim, Gulden Menderes, et al.. (2018). Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer. Journal of Cancer Research and Clinical Oncology. 144(12). 2449–2456. 20 indexed citations

Menderes, Gulden, Elena Bonazzoli, Stefania Bellone, et al.. (2017). SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/Neu expression. Gynecologic Oncology. 146(1). 179–186. 35 indexed citations

Altwerger, Gary, Gregory M. Gressel, Diana P. English, et al.. (2016). Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study. Gynecologic Oncology. 144(1). 77–82. 30 indexed citations

Roque, Dana M., Natália Buza, Stefania Bellone, et al.. (2013). Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxel. Clinical & Experimental Metastasis. 31(1). 101–110. 38 indexed citations

ElSahwi, Karim, Emma L. Barber, Jessica L. Illuzzi, et al.. (2011). The significance of perineural invasion in early-stage cervical cancer. Gynecologic Oncology. 123(3). 561–564. 24 indexed citations

Cocco, Emiliano, Joyce Varughese, Natália Buza, et al.. (2011). Expression of Tissue factor in Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix: Implications for immunotherapy with hI-con1, a factor VII-IgGFcchimeric protein targeting tissue factor. BMC Cancer. 11(1). 263–263. 35 indexed citations

Bellone, Stefania, Simone Anfossi, Timothy J. O’Brien, et al.. (2008). Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer. American Journal of Obstetrics and Gynecology. 200(1). 75.e1–75.e10. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact